Mission Statement​

he Bell Eve, Inc Office-Based Opioid Treatment (OBOT) has adopted evidence-based treatment recommendations for opioid use disorder and/or other substance use disorders set forth by the following federal agencies: Substance Abuse and Mental Health Services Administration (SAMHSA), American Society of Addiction Medicine (ASAM), and the US Food and Drug Administration (FDA) to promote the best person served  outcomes possible in alignment with Bell Eve, Inc Office-Based Opioid Treatment (OBOT) Mission, Vision, and Values. Bell Eve, Inc Office-Based Opioid Treatment (OBOT) Program practices are based on lessons learned over the past decade of addiction research. Our philosophy is that addiction is a chronic disease that negatively affects a person’s ability to function in an emotional, physical, and spiritual capacity. Our program’s philosophy is less reliant on rule-based protocols and more on an interdisciplinary team approach to make important and sometimes difficult clinical treatment decisions. Because of the complexity of the illness, Bell Eve, Inc Office-Based Opioid Treatment (OBOT) Program’s overall goal of medication-assisted treatment is to improve quality of life and freedom from illicit drugs.